JP2009538328A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009538328A5 JP2009538328A5 JP2009512225A JP2009512225A JP2009538328A5 JP 2009538328 A5 JP2009538328 A5 JP 2009538328A5 JP 2009512225 A JP2009512225 A JP 2009512225A JP 2009512225 A JP2009512225 A JP 2009512225A JP 2009538328 A5 JP2009538328 A5 JP 2009538328A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- phenyl
- hexyl
- hept
- dichloro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 15
- 239000000203 mixture Substances 0.000 claims 4
- 208000010412 Glaucoma Diseases 0.000 claims 3
- 206010030043 Ocular hypertension Diseases 0.000 claims 3
- 125000004432 carbon atom Chemical group C* 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 229910052717 sulfur Inorganic materials 0.000 claims 3
- -1 6-hexyl Chemical group 0.000 claims 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical group CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical class C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 239000000651 prodrug Substances 0.000 claims 2
- 229940002612 prodrug Drugs 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- ZZPVJHFTTJXWMD-IUMCTMNXSA-N (z)-7-[(1r,2s,3r,5r)-3,5-dichloro-2-[4-(1-hydroxyhexyl)phenyl]cyclopentyl]hept-5-enoic acid Chemical compound C1=CC(C(O)CCCCC)=CC=C1[C@@H]1[C@@H](C\C=C/CCCC(O)=O)[C@H](Cl)C[C@H]1Cl ZZPVJHFTTJXWMD-IUMCTMNXSA-N 0.000 claims 1
- ZZPVJHFTTJXWMD-LQUPIGEUSA-N (z)-7-[(1r,2s,3s,5r)-3,5-dichloro-2-[4-(1-hydroxyhexyl)phenyl]cyclopentyl]hept-5-enoic acid Chemical compound C1=CC(C(O)CCCCC)=CC=C1[C@@H]1[C@@H](C\C=C/CCCC(O)=O)[C@H](Cl)C[C@@H]1Cl ZZPVJHFTTJXWMD-LQUPIGEUSA-N 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 235000010290 biphenyl Nutrition 0.000 claims 1
- 239000004305 biphenyl Substances 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 125000000524 functional group Chemical group 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 125000005549 heteroarylene group Chemical group 0.000 claims 1
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- AKTZNVYKRQZIMN-BKCYZJPNSA-N methyl (z)-7-[(1r,2s,3r,5r)-3,5-dichloro-2-[4-(1-hydroxyhexyl)phenyl]cyclopentyl]hept-5-enoate Chemical compound C1=CC(C(O)CCCCC)=CC=C1[C@@H]1[C@@H](C\C=C/CCCC(=O)OC)[C@H](Cl)C[C@H]1Cl AKTZNVYKRQZIMN-BKCYZJPNSA-N 0.000 claims 1
- AKTZNVYKRQZIMN-CIZPOVBOSA-N methyl (z)-7-[(1r,2s,3s,5r)-3,5-dichloro-2-[4-(1-hydroxyhexyl)phenyl]cyclopentyl]hept-5-enoate Chemical compound C1=CC(C(O)CCCCC)=CC=C1[C@@H]1[C@@H](C\C=C/CCCC(=O)OC)[C@H](Cl)C[C@@H]1Cl AKTZNVYKRQZIMN-CIZPOVBOSA-N 0.000 claims 1
- 125000002950 monocyclic group Chemical group 0.000 claims 1
- 150000007524 organic acids Chemical group 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- NXZMSAVZNLOSHL-ZAKVNNCQSA-N propan-2-yl (z)-7-[(1r,2s,3r,5r)-3,5-dichloro-2-[4-(1-hydroxyhexyl)phenyl]cyclopentyl]hept-5-enoate Chemical compound C1=CC(C(O)CCCCC)=CC=C1[C@@H]1[C@@H](C\C=C/CCCC(=O)OC(C)C)[C@H](Cl)C[C@H]1Cl NXZMSAVZNLOSHL-ZAKVNNCQSA-N 0.000 claims 1
- NXZMSAVZNLOSHL-ZURXIWKOSA-N propan-2-yl (z)-7-[(1r,2s,3s,5r)-3,5-dichloro-2-[4-(1-hydroxyhexyl)phenyl]cyclopentyl]hept-5-enoate Chemical compound C1=CC(C(O)CCCCC)=CC=C1[C@@H]1[C@@H](C\C=C/CCCC(=O)OC(C)C)[C@H](Cl)C[C@@H]1Cl NXZMSAVZNLOSHL-ZURXIWKOSA-N 0.000 claims 1
- 125000003107 substituted aryl group Chemical group 0.000 claims 1
- 125000003831 tetrazolyl group Chemical group 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74783506P | 2006-05-22 | 2006-05-22 | |
| US60/747,835 | 2006-05-22 | ||
| PCT/US2007/069120 WO2007140136A2 (en) | 2006-05-22 | 2007-05-17 | Therapeutic cyclopentane derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009538328A JP2009538328A (ja) | 2009-11-05 |
| JP2009538328A5 true JP2009538328A5 (enExample) | 2010-07-01 |
| JP5269772B2 JP5269772B2 (ja) | 2013-08-21 |
Family
ID=38658444
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009512225A Expired - Fee Related JP5269772B2 (ja) | 2006-05-22 | 2007-05-17 | 治療用シクロペンタン誘導体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7547727B2 (enExample) |
| EP (2) | EP2845849A1 (enExample) |
| JP (1) | JP5269772B2 (enExample) |
| AU (1) | AU2007267653B2 (enExample) |
| BR (1) | BRPI0712025A2 (enExample) |
| CA (1) | CA2652990A1 (enExample) |
| WO (1) | WO2007140136A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090016981A1 (en) * | 2006-05-03 | 2009-01-15 | Allergan, Inc. | Therapeutic compounds |
| JP5532302B2 (ja) | 2006-07-10 | 2014-06-25 | アラーガン インコーポレイテッド | 治療化合物 |
| US7964596B2 (en) * | 2008-03-07 | 2011-06-21 | Allergan, Inc. | Therapeutic compounds |
| US7960378B2 (en) * | 2008-03-18 | 2011-06-14 | Allergan, Inc. | Therapeutic compounds |
| EP2303836A1 (en) * | 2008-05-09 | 2011-04-06 | Allergan, Inc. | Therapeutic cyclopentane derivatives |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3975421A (en) * | 1974-09-05 | 1976-08-17 | American Home Products Corporation | 15-Substituted 11α-cyano-prostaglandins and related compounds |
| US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
| US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
| US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
| US5462968A (en) * | 1994-01-19 | 1995-10-31 | Allergan, Inc. | EP2 -receptor agonists as agents for lowering intraocular pressure |
| US5902726A (en) * | 1994-12-23 | 1999-05-11 | Glaxo Wellcome Inc. | Activators of the nuclear orphan receptor peroxisome proliferator-activated receptor gamma |
| AU770343B2 (en) | 1999-09-06 | 2004-02-19 | Fumie Sato | Prostaglandin E analogues |
| US7091231B2 (en) * | 2004-12-10 | 2006-08-15 | Allergan, Inc. | 12-Aryl prostaglandin analogs |
-
2007
- 2007-05-11 US US11/747,478 patent/US7547727B2/en active Active
- 2007-05-17 BR BRPI0712025-7A patent/BRPI0712025A2/pt not_active IP Right Cessation
- 2007-05-17 CA CA002652990A patent/CA2652990A1/en not_active Abandoned
- 2007-05-17 EP EP14176097.5A patent/EP2845849A1/en not_active Withdrawn
- 2007-05-17 AU AU2007267653A patent/AU2007267653B2/en not_active Ceased
- 2007-05-17 EP EP07797536.5A patent/EP2021323B1/en not_active Not-in-force
- 2007-05-17 JP JP2009512225A patent/JP5269772B2/ja not_active Expired - Fee Related
- 2007-05-17 WO PCT/US2007/069120 patent/WO2007140136A2/en not_active Ceased